[1]
A. R. S. Khan and R. Bai, “Preemptive EBV-specific T-cell therapy: an emerging prophylactic approach to PTLD reduction and survival benefit in SOT recipients”, J Pak Med Assoc, vol. 76, no. 02, pp. 280–280, Jan. 2026.